Carregant...
Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
Guardat en:
| Publicat a: | J Curr Ophthalmol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859497/ https://ncbi.nlm.nih.gov/pubmed/29564403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2018.01.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|